| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/01/1996 | CA2033499C Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 09/30/1996 | CA2171782A1 Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines |
| 09/26/1996 | WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 09/26/1996 | WO1996029411A1 Protein production and delivery |
| 09/26/1996 | WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6 |
| 09/26/1996 | WO1996029395A1 Cell culture method |
| 09/26/1996 | WO1996029332A1 Process for isolating galanthamine |
| 09/26/1996 | WO1996029328A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 09/26/1996 | WO1996029326A1 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 09/26/1996 | WO1996029317A1 Aromatic compounds useful as tachykinin antagonists |
| 09/26/1996 | WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists |
| 09/26/1996 | WO1996029304A1 Nonpeptides as tachykinin antagonists |
| 09/26/1996 | WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 09/26/1996 | WO1996029075A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| 09/26/1996 | WO1996029066A1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 09/26/1996 | WO1996022774A3 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins |
| 09/26/1996 | WO1996017924A3 Novel hedgehog-derived polypeptides |
| 09/26/1996 | DE4396528C1 Abalone shell powder and sesame oil compsn for burn treatment |
| 09/26/1996 | CA2215730A1 Human metabotropic glutamate receptor subtype mglur6 |
| 09/26/1996 | CA2215700A1 Aromatic compounds useful as tachykinin antagonists |
| 09/26/1996 | CA2215699A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 09/26/1996 | CA2215618A1 Protein production and delivery |
| 09/26/1996 | CA2215322A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| 09/26/1996 | CA2214385A1 Cell culture method |
| 09/26/1996 | CA2211191A1 Nonpeptides as tachykinin antagonists |
| 09/26/1996 | CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists |
| 09/25/1996 | EP0733635A1 Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation |
| 09/25/1996 | EP0733628A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| 09/25/1996 | EP0733372A2 Pharmaceutical base for the formulation of nanosuspensions |
| 09/25/1996 | EP0733367A1 Oral olanzapine formulation |
| 09/25/1996 | EP0733360A2 Use of a combination of arachidonic acid and dosohexaenoic acid in the preparation of e medicament for treating cell membrane abnormalities due to low C20 or C22 essential fatty acids |
| 09/25/1996 | EP0733358A2 Nanosuspensions for intravenous application |
| 09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
| 09/25/1996 | EP0733067A1 N-terminally chemically modified protein compositions and methods |
| 09/25/1996 | EP0733066A1 Pretargeting methods and compounds |
| 09/25/1996 | EP0733051A1 Bicyclic heterocycles as neurokinin a antagonists |
| 09/25/1996 | EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists |
| 09/25/1996 | EP0733047A1 Novel substituted oxazolidines |
| 09/25/1996 | EP0733033A1 Pharmaceutically active substituted aromatic compounds |
| 09/25/1996 | EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 09/25/1996 | EP0732938A1 Method of treating intestinal disorders |
| 09/25/1996 | EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 09/25/1996 | EP0732926A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 09/25/1996 | EP0732925A1 A method of treating gastrointestinal motility disorders |
| 09/25/1996 | EP0732924A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 09/25/1996 | EP0732917A1 Nutritional supplement for optimizing cellular health |
| 09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 09/25/1996 | CN1131911A Anthracyclinone derivatives and their use in amyloidosis |
| 09/25/1996 | CN1131666A Tricyclic pyrazole derivatives |
| 09/25/1996 | CN1131664A New highly selective process for preparation of enantiomerically fure phenylsubstituted 1,4-dihydropyidine-3,5-dicarboxylic acid derivatives |
| 09/24/1996 | US5559269 Anticholinergic agents |
| 09/24/1996 | US5559238 N-substituted trifluoromethylphenyltetrahydropyridenes process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 09/24/1996 | US5559152 Pharmaceutical composition having antiacoholic activity |
| 09/24/1996 | US5559143 Anxiolytics, antidepressants, hypotensive agents, treatment of migraine |
| 09/24/1996 | US5559138 Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Tetrahydropyridines |
| 09/24/1996 | US5559136 Treatment of Alzheimer's disease using azacyclic compounds |
| 09/24/1996 | US5559130 Pyrrolidinyl pyridones for treating pain |
| 09/24/1996 | US5559126 Analgesics, antipsychotic agents |
| 09/24/1996 | US5559125 Nmda and ampa receptor antagonists, schizophrenia |
| 09/24/1996 | US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
| 09/24/1996 | US5559117 N-[(4-heteroaryl-1-piperazinyl) alkyl]-2-Benoxazolinines and related compounds and their therapeutic utility |
| 09/24/1996 | US5559116 Analgesics, antipsychotic agents |
| 09/24/1996 | US5559113 Imidazole compounds and their therapeutic applications |
| 09/24/1996 | US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 09/24/1996 | US5559106 Heterocyclic compounds, their use and preparation |
| 09/24/1996 | US5558987 Anxiolytic drug as stress relievers by reducing blood cholecystokinin |
| 09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
| 09/22/1996 | CA2172111A1 Nanosuspensions for intravenous administration |
| 09/22/1996 | CA2172110A1 Pharmaceutical carriers for nanosuspensions |
| 09/19/1996 | WO1996028471A1 Modulators of amyloid aggregation |
| 09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 09/19/1996 | WO1996028424A1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity |
| 09/19/1996 | WO1996028187A1 Method for treating amyloidosis |
| 09/19/1996 | WO1996028180A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes |
| 09/19/1996 | WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 09/19/1996 | WO1996028146A1 Novel naphthyl pharmaceutical compounds |
| 09/19/1996 | WO1996019499A3 Improved cyclic crf antagonists |
| 09/19/1996 | WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/19/1996 | DE4090006C2 Purified sciatic nerve ciliary neurotrophic factor |
| 09/19/1996 | DE19509663A1 Verfahren zur Isolierung von Galanthamin A method for the isolation of galanthamine |
| 09/19/1996 | CA2449296A1 Modulators of amyloid aggregation |
| 09/19/1996 | CA2214999A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes |
| 09/19/1996 | CA2214416A1 Novel naphthyl pharmaceutical compounds |
| 09/18/1996 | EP0732399A2 Chymotrypsin-like proteases and their inhibitors |
| 09/18/1996 | EP0732334A1 Piperidine derivatives, process for their preparation and their therapeutic application |
| 09/18/1996 | EP0732333A1 Indazolecarboxamides |
| 09/18/1996 | EP0732332A1 Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation |
| 09/18/1996 | EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals |
| 09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 09/18/1996 | EP0731811A1 Chaperonin 10 |
| 09/18/1996 | EP0731802A1 N-substituted azabicycloalkane derivatives as neuroleptika asf |
| 09/18/1996 | EP0731796A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation |
| 09/18/1996 | EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| 09/18/1996 | EP0731793A1 1,5-diphenyl pyrazole compounds for treatment of inflammation |
| 09/18/1996 | EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 09/18/1996 | EP0731790A1 Tachykinin antagonists |
| 09/18/1996 | EP0731788A1 Prolyl endopeptidase inhibitors |
| 09/18/1996 | EP0731698A1 Modafinil having defined particle size |
| 09/18/1996 | EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups |